InvestSMART

Starpharma Holdings Limited (ASX: SPL) - Announcements

Current share price for SPL : $0.693 0.002 (0.36%)+

ASX company news and announcements for Starpharma Holdings Limited (SPL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Starpharma Holdings Limited (SPL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Starpharma Holdings Limited (SPL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Starpharma Holdings Limited (SPL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$290 SPL7013 Nasal Spray Australia Update 18 Oct 2024 9:22AM $0.093 $0.690 risen by 641.94%
$290 Date of Annual General Meeting 2024 3 Oct 2024 3:55PM $0.097 $0.690 risen by 611.34%
$290 Notification of cessation of securities - SPL 3 Oct 2024 9:21AM $0.100 $0.690 risen by 590%
$290 Change of Director's Interest Notice - Dr Russell Basser 16 Sep 2024 3:22PM $0.100 $0.690 risen by 590%
$290 Starpharma Receives $5.5M R&D Tax Incentive Refund 12 Sep 2024 9:30AM $0.093 $0.690 risen by 641.94%
$290 Ceasing to be a substantial holder 9 Sep 2024 4:43PM $0.095 $0.690 risen by 626.32%
$290 Change in Director's Interest Notice - David McIntyre 2 Sep 2024 1:53PM $0.105 $0.690 risen by 557.14%
$290 Change in Director's Interest Notice - R Thomas 2 Sep 2024 1:50PM $0.105 $0.690 risen by 557.14%
$290 Application for quotation of securities - SPL 28 Aug 2024 2:08PM $0.095 $0.690 risen by 626.32%
$290 Change in substantial holding 27 Aug 2024 4:44PM $0.095 $0.690 risen by 626.32%
$290 Appendix 4G and Corporate Governance Statement 22 Aug 2024 9:11AM $0.088 $0.690 risen by 684.09%
$290 Annual Report to shareholders 22 Aug 2024 9:09AM $0.088 $0.690 risen by 684.09%
$290 Change in substantial holding 16 Aug 2024 4:00PM $0.092 $0.690 risen by 650%
$290 Change in substantial holding 2 Aug 2024 4:15PM $0.093 $0.690 risen by 641.94%
$290 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jul 2024 9:14AM $0.097 $0.690 risen by 611.34%
$290 Change in substantial holding 2 Jul 2024 4:38PM $0.093 $0.690 risen by 641.94%
$290 Application for quotation of securities - SPL 2 Jul 2024 2:16PM $0.096 $0.690 risen by 618.75%
$290 Change in Director's Interest Notice - Jeff Davies 1 Jul 2024 12:20PM $0.091 $0.690 risen by 658.24%
$290 Change in substantial holding 28 Jun 2024 6:04PM $0.095 $0.690 risen by 626.32%
$290 Change in Director's Interest Notice - L Cheng 27 Jun 2024 2:07PM $0.089 $0.690 risen by 675.28%
$290 Change in Director's Interest Notice - R Thomas 27 Jun 2024 2:06PM $0.089 $0.690 risen by 675.28%
$290 Change in substantial holding 25 Jun 2024 4:42PM $0.089 $0.690 risen by 675.28%
$290 Change in Director's Interest Notice - R Thomas 21 Jun 2024 10:07AM $0.090 $0.690 risen by 666.67%
$290 DEP presentation at SNMMI radiopharmaceuticals conference 11 Jun 2024 4:09PM $0.100 $0.690 risen by 590%
$290 Notification regarding unquoted securities - SPL 11 Jun 2024 1:51PM $0.100 $0.690 risen by 590%

76 - 100 of 864 results

Page 4 of 35

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.